Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Opioid-Induced Constipation (OIC)”

Showing 20 of 0 results

Post-approval studies (Phase 4)Ended earlyNCT00799201
What this trial is testing

Enteral Naloxone Versus a Traditional Bowel Regimen for the Prevention of Opioid Induced Constipation in Trauma Patients

Who this might be right for
ConstipationAnalgesia
CAMC Health System 3
Post-approval studies (Phase 4)WithdrawnNCT00858754
What this trial is testing

Study Evaluating Safety & Efficacy of Subcutaneous Methylnaltrexone on Opioid-Induced Constipation in Cancer Subjects

Who this might be right for
Opioid-Induced Constipation
Bausch Health Americas, Inc.
Testing effectiveness (Phase 2)Looking for participantsNCT05588323
What this trial is testing

Safety and Pharmacokinetics Study of Naldemedine in Paediatric Participants Receiving Opioids

Who this might be right for
Opioid-Induced Constipation (OIC)
Shionogi 24
Large-scale testing (Phase 3)Study completedNCT00804141
What this trial is testing

Study Evaluating Long-Term Safety of MOA-728 in Participants With Opioid-Induced Constipation

Who this might be right for
Constipation
Bausch Health Americas, Inc. 1,040
Post-approval studies (Phase 4)Study completedNCT05770960
What this trial is testing

Colonic Motor Patterns in Healthy Volunteers

Who this might be right for
Opioid-Induced Constipation
Universitaire Ziekenhuizen KU Leuven 15
Testing effectiveness (Phase 2)Study completedNCT00600119
What this trial is testing

A Phase 2, Double-Blind, Multiple-Dose Escalation Study to Evaluate NKTR-118 (Oral PEG-Naloxol) in Patients With Opioid-Induced Constipation (OIC)

Who this might be right for
Opioid Induced Constipation (OIC)
AstraZeneca 207
Testing effectiveness (Phase 2)Study completedNCT02137213
What this trial is testing

Feasibility Study of Oral Naloxone for Treatment of Methadone-induced Constipation

Who this might be right for
Constipation
Centre for Addiction and Mental Health 20
Not applicableStudy completedNCT04404933
What this trial is testing

Study of Opioid-Induced Constipation 2 Project

Who this might be right for
Opioid-induced ConstipationCancerCancer Pain
Royal Surrey County Hospital NHS Foundation Trust 100
Testing effectiveness (Phase 2)Study completedNCT01382797
What this trial is testing

ALK37-005: A Study of ALKS 37 (RDC-1036) in Adults With Opioid-induced Constipation (OIC)

Who this might be right for
Opioid-induced Constipation
Alkermes, Inc. 157
Large-scale testing (Phase 3)Study completedNCT00620061
What this trial is testing

Opioid-induced Bowel Dysfunction: Long-Term Assessment of Lubiprostone

Who this might be right for
Opioid-Induced Bowel Dysfunction
Sucampo Pharma Americas, LLC 439
Large-scale testing (Phase 3)Ended earlyNCT01901328
What this trial is testing

Efficacy and Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation

Who this might be right for
Opioid-Induced Constipation
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 49
Not applicableStudy completedNCT01812733
What this trial is testing

Non-interventional Study Comparing Targiniq and Oxycodone/Laxatives

Who this might be right for
PainOpioid Induced Constipation
Mundipharma AB 37
Large-scale testing (Phase 3)Ended earlyNCT01014559
What this trial is testing

Efficacy of Oxycodone/Naloxone(OXN), Versus Oxycodone (OXY), for the Reduction of Intensity of Opioid-induced Constipation in Pain Patients

Who this might be right for
ConstipationPain
Mundipharma SAS 225
Large-scale testing (Phase 3)Ended earlyNCT01384292
What this trial is testing

Assessment of Efficacy and Safety in Relieving Opioid-induced Constipation in Patients With Cancer-related Pain

Who this might be right for
Opioid-Induced Constipation
AstraZeneca 14
Testing effectiveness (Phase 2)Study completedNCT01100151
What this trial is testing

ALK37-003: A Study of RDC-1036 (ALKS 37) in Adults With Opioid-induced Constipation (OIC)

Who this might be right for
Opioid-induced Constipation
Alkermes, Inc. 60
Post-approval studies (Phase 4)Not Yet RecruitingNCT06897917
What this trial is testing

Real World Study of Oxycodone/Naloxone Sustained-Release Tablets (Mimeixin) for Patients With Severe Cancer Pain

Who this might be right for
Opioid-Induced ConstipationPain Cancer
Henan Cancer Hospital 203
Testing effectiveness (Phase 2)UnknownNCT06334198
What this trial is testing

The Effect of Naldemedine on Opioid-induced Bowel Dysfunction

Who this might be right for
Opioid-Induced Bowel DysfunctionConstipation
Asbjørn Mohr Drewes 20
Not applicableUnknownNCT04876508
What this trial is testing

The Efficacy of Acupressure in Managing Opioid-induced Constipation

Who this might be right for
Opioid-induced Bowel DysfunctionConstipation Drug Induced
Istanbul Aydın University 120
Testing effectiveness (Phase 2)Study completedNCT00366431
What this trial is testing

Study Evaluating Oral MOA-728 for the Treatment of Opioid-Induced Bowel Dysfunction (OIBD) in Subjects With Chronic Non-Malignant Pain

Who this might be right for
Constipation
Bausch Health Americas, Inc. 420
Large-scale testing (Phase 3)Study completedNCT01395524
What this trial is testing

A 12-week Extension of the Phase III Study (D3820C00004) to Assess the Effect and Safety of NKTR-118 in Patients With Non-cancer-related Pain and Opioid-induced Constipation

Who this might be right for
Opioid-Induced Constipation (OIC)
AstraZeneca 302
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation